Velcade 3.5 mg Injection
615.93$
480.42$
Velcade 3.5 mg injection is a targeted anticancer therapy designed to combat multiple myeloma, a malignant condition affecting bone marrow, as well as mantle cell lymphoma, an aggressive cancer originating from immune system cells. This innovative treatment works by inhibiting specific proteins within cancer cells, effectively disrupting their function and leading to cell death. By blocking these proteins, Velcade helps to slow disease progression and improve patient outcomes. It is essential for patients to discuss potential side effects and contraindications with their healthcare provider, as Velcade may not be suitable for everyone, especially those with certain pre-existing conditions. Regular monitoring during treatment is crucial to ensure the best possible response and to manage any adverse reactions. As a vital option in the fight against these challenging cancers, Velcade 3.5 mg injection represents a significant advancement in oncology. Patients considering this treatment should consult their oncologist to understand how it can fit into their overall cancer management plan.
الكمية
Active Pharmaceutical Ingredient
Uses
• Velcade 3 5 mg injection is primarily used for the treatment of multiple myeloma, a cancer that affects plasma cells in the bone marrow. These abnormal plasma cells disrupt the production of healthy blood cells, leading to various symptoms. Patients may experience bone pain, fatigue, and recurrent infections due to this condition. By targeting the underlying disease process, Velcade helps improve the quality of life for individuals battling multiple myeloma.
• Another critical application of Velcade 3 5 mg injection is in the management of mantle cell lymphoma. This rare and aggressive form of non-Hodgkin lymphoma originates from B cells and can lead to significant health challenges. Patients with mantle cell lymphoma often suffer from symptoms such as swollen lymph nodes, weight loss, and night sweats. Velcade assists in controlling the progression of this disease and alleviating associated symptoms.
• Velcade 3 5 mg injection may also be utilized in combination therapies for patients with relapsed or refractory multiple myeloma. In such scenarios, it can enhance the effectiveness of other treatment modalities. This approach allows for a more comprehensive strategy in managing the disease, especially in cases where prior treatments have not yielded satisfactory results. By incorporating Velcade into their treatment plan, patients may experience improved responses to therapy.
• In addition to its primary uses, Velcade 3 5 mg injection is sometimes employed for patients with specific treatment-resistant conditions related to hematologic malignancies. Its ability to inhibit proteasome activity makes it a valuable option in complex cases. As a result, healthcare providers may consider Velcade for patients who have limited treatment options available. This flexibility in use helps address the diverse needs of individuals with challenging cancer diagnoses.
Benefits
Velcade 3.5 mg Injection contains the active substance bortezomib, also called ‘proteome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, it can kill cancer cells. Velcade 3.5 mg is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer affecting the lymph nodes) in people 18 years or older. It may be used alone or together with other medicines.
Side Effects
Like all medications, Velcade 3.5 mg Vial can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Burning feeling of skin
• Stomach Pain
• Insomnia
• Dehydration
• Pneumonia
• High fever
Common Side Effects
• High Blood Pressure
• Tiredness
• Cough
• Chest Tightness
• Feet Swelling
How To Use
Velcade 3.5 mg is administered intravenously or subcutaneously at a hospital or clinic setting by a doctor or nurse. Your doctor will decide the right time to take the injection, so always follow your doctor's advice. The dose and how often you take it depend on what you are taking it for. You might be prescribed certain other medicine as a part of your treatment. You should take this medicine for as long as it is prescribed for you.
Safety Advice
• Alcohol: Consumption of alcohol is not recommended while using Velcade 3.5 mg Vial. Alcohol may increase or decrease the effectiveness of the medicine and also increase the risk of side effects. It is the best advice for you: before consuming alcohol, you can talk with a doctor or pharmacist, and they will tell you if consumption of alcohol is safe or not.
• Kidney: Velcade 3.5 mg Vial should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Bortezomib Injection 3.5 mg and report any unusual symptoms or changes in kidney function to their doctor. Your doctor may need to adjust the dose in such kidney disease patients.
• Breastfeeding: It is unknown whether Velcade Injection is excreted in human milk. If you are breastfeeding and taking this medicine. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Velcade 3.5 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Bortezomib Injection 3.5 mg and report any unusual symptoms or changes in liver function to their doctor. Your doctor may need to adjust the dose in such liver disease patients.
• Pregnancy: Animal reproduction studies have not been conducted with Velcade Injection. Velcade 3.5 mg Injection is generally considered unsafe during pregnancy. If you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Velcade 3.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Velcade 3.5 mg Injection will not affect your ability to drive or operate machinery. In case you experience any side effects while taking Bortezomib Injection 3.5 mg, such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.